🇺🇸 FDA
Patent

US 10532106

Bicyclic peptide ligands specific for MT1-MMP

granted A61KA61K31/195A61K47/547

Quick answer

US patent 10532106 (Bicyclic peptide ligands specific for MT1-MMP) held by BicycleRD Limited expires Mon Jan 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
BicycleRD Limited
Grant date
Tue Jan 14 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/195, A61K47/547, A61K47/64, A61K51/0482